Literature DB >> 33331820

Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia.

Michaela Gregorova1, Daniel Morse1, Tarcisio Brignoli1, Laura Rivino1, Ruth C Massey1, Joseph Steventon1, Fergus Hamilton2, Mahableshwar Albur2, David Arnold2, Matthew Thomas2, Alice Halliday1, Holly Baum1, Christopher Rice1, Matthew B Avison1, Andrew D Davidson1, Marianna Santopaolo1, Elizabeth Oliver1, Anu Goenka1, Adam Finn1, Linda Wooldridge3, Borko Amulic1, Rosemary J Boyton4,5, Daniel M Altmann4, David K Butler4, Claire McMurray6, Joanna Stockton6, Sam Nicholls6, Charles Cooper6, Nicholas Loman6, Michael J Cox5.   

Abstract

Here, we describe the case of a COVID-19 patient who developed recurring ventilator-associated pneumonia caused by Pseudomonas aeruginosa that acquired increasing levels of antimicrobial resistance (AMR) in response to treatment. Metagenomic analysis revealed the AMR genotype, while immunological analysis revealed massive and escalating levels of T-cell activation. These were both SARS-CoV-2 and P. aeruginosa specific, and bystander activated, which may have contributed to this patient's persistent symptoms and radiological changes.
© 2020, Gregorova et al.

Entities:  

Keywords:  Pseudomonas aeruginosa; SARS-CoV-2; human; infectious disease; metagenomics; microbiology; t-cells activation

Mesh：

Substances：

Year:  2020        PMID： 33331820      PMCID： PMC7775105          DOI： 10.7554/eLife.63430

Source DB:  PubMed          Journal:  Elife        ISSN： 2050-084X            Impact factor:   8.713


  31 in total

1.  Mutations affecting DNA-binding activity of the MexR repressor of mexR-mexA-mexB-oprM operon expression.

Authors:  Kohjiro Saito; Hiroyuki Akama; Eisaku Yoshihara; Taiji Nakae
Journal:  J Bacteriol       Date:  2003-10       Impact factor: 3.490

Review 2.  Properties of end-stage human T cells defined by CD45RA re-expression.

Authors:  Sian M Henson; Natalie E Riddell; Arne N Akbar
Journal:  Curr Opin Immunol       Date:  2012-05-01       Impact factor: 7.486

3.  Assembly of long, error-prone reads using repeat graphs.

Authors:  Mikhail Kolmogorov; Jeffrey Yuan; Yu Lin; Pavel A Pevzner
Journal:  Nat Biotechnol       Date:  2019-04-01       Impact factor: 54.908

4.  BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons.

Authors:  Nabil-Fareed Alikhan; Nicola K Petty; Nouri L Ben Zakour; Scott A Beatson
Journal:  BMC Genomics       Date:  2011-08-08       Impact factor: 3.969

5.  A serological assay to detect SARS-CoV-2 seroconversion in humans.

Authors:  Fatima Amanat; Daniel Stadlbauer; Shirin Strohmeier; Thi H O Nguyen; Veronika Chromikova; Meagan McMahon; Kaijun Jiang; Guha Asthagiri Arunkumar; Denise Jurczyszak; Jose Polanco; Maria Bermudez-Gonzalez; Giulio Kleiner; Teresa Aydillo; Lisa Miorin; Daniel S Fierer; Luz Amarilis Lugo; Erna Milunka Kojic; Jonathan Stoever; Sean T H Liu; Charlotte Cunningham-Rundles; Philip L Felgner; Thomas Moran; Adolfo García-Sastre; Daniel Caplivski; Allen C Cheng; Katherine Kedzierska; Olli Vapalahti; Jussi M Hepojoki; Viviana Simon; Florian Krammer
Journal:  Nat Med       Date:  2020-05-12       Impact factor: 53.440

6.  Fast and accurate de novo genome assembly from long uncorrected reads.

Authors:  Robert Vaser; Ivan Sović; Niranjan Nagarajan; Mile Šikić
Journal:  Genome Res       Date:  2017-01-18       Impact factor: 9.043

7.  Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications.

Authors:  Divij Mathew; Josephine R Giles; Amy E Baxter; Derek A Oldridge; Allison R Greenplate; Jennifer E Wu; Cécile Alanio; Leticia Kuri-Cervantes; M Betina Pampena; Kurt D'Andrea; Sasikanth Manne; Zeyu Chen; Yinghui Jane Huang; John P Reilly; Ariel R Weisman; Caroline A G Ittner; Oliva Kuthuru; Jeanette Dougherty; Kito Nzingha; Nicholas Han; Justin Kim; Ajinkya Pattekar; Eileen C Goodwin; Elizabeth M Anderson; Madison E Weirick; Sigrid Gouma; Claudia P Arevalo; Marcus J Bolton; Fang Chen; Simon F Lacey; Holly Ramage; Sara Cherry; Scott E Hensley; Sokratis A Apostolidis; Alexander C Huang; Laura A Vella; Michael R Betts; Nuala J Meyer; E John Wherry
Journal:  Science       Date:  2020-07-15       Impact factor: 47.728

Review 8.  Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.

Authors:  Bradley J Langford; Miranda So; Sumit Raybardhan; Valerie Leung; Duncan Westwood; Derek R MacFadden; Jean-Paul R Soucy; Nick Daneman
Journal:  Clin Microbiol Infect       Date:  2020-07-22       Impact factor: 8.067

9.  Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.

Authors:  Alba Grifoni; Daniela Weiskopf; Sydney I Ramirez; Jose Mateus; Jennifer M Dan; Carolyn Rydyznski Moderbacher; Stephen A Rawlings; Aaron Sutherland; Lakshmanane Premkumar; Ramesh S Jadi; Daniel Marrama; Aravinda M de Silva; April Frazier; Aaron F Carlin; Jason A Greenbaum; Bjoern Peters; Florian Krammer; Davey M Smith; Shane Crotty; Alessandro Sette
Journal:  Cell       Date:  2020-05-20       Impact factor: 66.850

10.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321
View more
  9 in total

1.  Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection.

Authors:  Chansavath Phetsouphanh; David R Darley; Anthony D Kelleher; Gail V Matthews; Daniel B Wilson; Annett Howe; C Mee Ling Munier; Sheila K Patel; Jennifer A Juno; Louise M Burrell; Stephen J Kent; Gregory J Dore
Journal:  Nat Immunol       Date:  2022-01-13       Impact factor: 31.250

2.  A niclosamide-tobramycin hybrid adjuvant potentiates cefiderocol against P. aeruginosa.

Authors:  Liam Berry; Marc Brizuela; Gregory Jackson; Frank Schweizer
Journal:  RSC Med Chem       Date:  2021-07-27

Review 3.  Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infectionImmunity and inflammaion in post-acute sequelae of SARS-CoV-2 infection.

Authors:  Krista L Newell; Adam T Waickman
Journal:  Curr Opin Immunol       Date:  2022-05-24       Impact factor: 7.268

Review 4.  Bioactivity and Pharmacological Potential of Date Palm (Phoenix dactylifera L.) Against Pandemic COVID-19: a Comprehensive Review.

Authors:  Zulhisyam Abdul Kari; Mahmoud A O Dawood; Nik Shahman Nik Ahmad Ariff; Muhammad Rajaei Ahmad Mohd Zain; Zeti Norfidiyati Salmuna; Norzila Ismail; Al Hafiz Ibrahim; Kumara Thevan Krishnan; Nor Fazila Che Mat; Hisham Atan Edinur; Mohammad Khairul Azhar Abdul Razab; Aurifullah Mohammed; Sirajudeen Kuttulebbai Naina Mohamed Salam; Pasupuleti Visweswara Rao; Sakinah Mohamad; Basyarah Hamat; Shahriman Zainal Abidin; Lee Seong Wei; Amran Ahmed Shokri
Journal:  Appl Biochem Biotechnol       Date:  2022-05-17       Impact factor: 3.094

5.  Evolving phenotypes of non-hospitalized patients that indicate long COVID.

Authors:  Hossein Estiri; Zachary H Strasser; Gabriel A Brat; Yevgeniy R Semenov; Chirag J Patel; Shawn N Murphy
Journal:  BMC Med       Date:  2021-09-27       Impact factor: 11.150

Review 6.  Emerging role of bystander T cell activation in autoimmune diseases.

Authors:  Chae-Hyeon Shim; Sookyung Cho; Young-Mi Shin; Je-Min Choi
Journal:  BMB Rep       Date:  2022-02       Impact factor: 4.778

7.  Post COVID syndrome: A novel challenge and threat to international health.

Authors:  Indrajit Banerjee; Jared Robinson; Alexandra Leclézio; Brijesh Sathian; Indraneel Banerjee
Journal:  Nepal J Epidemiol       Date:  2022-06-30

8.  Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information.

Authors:  Halie M Rando; Tellen D Bennett; James Brian Byrd; Carolyn Bramante; Tiffany J Callahan; Christopher G Chute; Hannah E Davis; Rachel Deer; Joel Gagnier; Farrukh M Koraishy; Feifan Liu; Julie A McMurry; Richard A Moffitt; Emily R Pfaff; Justin T Reese; Rose Relevo; Peter N Robinson; Joel H Saltz; Anthony Solomonides; Anupam Sule; Umit Topaloglu; Melissa A Haendel
Journal:  medRxiv       Date:  2021-03-26

Review 9.  Long COVID, a comprehensive systematic scoping review.

Authors:  Hossein Akbarialiabad; Mohammad Hossein Taghrir; Ashkan Abdollahi; Nasrollah Ghahramani; Manasi Kumar; Shahram Paydar; Babak Razani; John Mwangi; Ali A Asadi-Pooya; Leila Malekmakan; Bahar Bastani
Journal:  Infection       Date:  2021-07-28       Impact factor: 3.553
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.